Interdisziplinär Diagnostizieren und Therapieren

• Literatur

• 1 Nabauer M, Oeff M, Gerth A. et al Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). Europace 2021; 23: 1903-1912
• 2 Haeusler KG, Gerth A, Limbourg T. et al Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry. BMC Neurol 2015; 15: 129
• 3 Boriani G, Proietti M, Laroche C. et al Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. Europace 2019; 21: 1013-1022
• 4 Haeusler KG, Kirchhof P, Kunze C. et al Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Lancet Neurol 2021; 20 (06) 426-436
• 5 Kirchhof P, Camm AJ, Goette A. et al Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 2020; 383 (14) 1305-1316
• 6 Kirchhof P, Haeusler KG, Blank B. et al Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J 2018; 39 (32) 2942-2955